Ileana L. Pina, MD, MPH (she/her/hers)

Professor of Medicine
Thomas Jefferson University
Cleveland hts, Ohio, United States

Ileana L. Piña, MD, MPH, FACC, FAHA is a heart failure / cardiac transplantation Cardiologist. She serves as an Senior Staff Fellow and Medical Reviewer to the FDA’s Center for Devices and Radiological Health. In January 2022, Dr. Piña joined the faculty of Thomas Jefferson University in February 2022 as Quality Chief. Dr. Piña is internationally recognized for her research in rehabilitation of heart failure patients. She is the author of over 300 publications in print, a world-renowned speaker on this subject. A volunteer for the American Heart Association, Dr Piña has been past Chair of the Council on clinical cardiology, a member of Get With the Guidelines, Scientific Committee. More recently, she was elected to the National Board of Directors for the American Heart Association. In 2022, Dr. Piña received the Bernadine Healy Award for Women's Heart Research from the ACC.

Presentation(s):

• SHOCK RESOURCES WORKING GROUP: AHA SHOCK REGISTRY

  Saturday, February 25, 2023
  1:40 PM – 2:10 PM ET

  Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)

• Shock Resources Working Group: AHA Shock Registry | Panel Discussion

  Saturday, February 25, 2023
  1:50 PM – 2:10 PM ET

  Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)

• Priorities for Collaborative Efforts and Cardiogenic Shock Going Forward

  Saturday, February 25, 2023
  2:50 PM – 3:10 PM ET

  Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)

• Gender and Race Disparities for Essential Hypertension - Do They Exist?

  Sunday, February 26, 2023
  10:07 AM – 10:15 AM ET

  Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)

• Panel Discussion: Best Practice for Establishing a HTN Patient Care Medical Based Pathway

  Sunday, February 26, 2023
  10:15 AM – 10:30 AM ET

  Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)

• CLINICAL TRIAL CHALLENGES FOR HEART FAILURE INTERVENTIONS: EVOLVING EMERGING MEDICAL THERAPIES AND ADAPTING TO A NEW NORMAL POST PANDEMIC

  Tuesday, February 28, 2023
  11:50 AM – 1:00 PM ET

  Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)

• Heart Failure in the Modern Era - Can We Conduct Them?

  Tuesday, February 28, 2023
  12:06 PM – 12:14 PM ET

  Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)

• Panel Discussion: How to Optimize Clinical Trials for Devices for Heart Failure in the Era of the Pandemic and New Medical Therapeutics

  Tuesday, February 28, 2023
  12:30 PM – 1:00 PM ET

  Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)